X-154030666-G-C

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4BP6_Very_StrongBS2

The NM_001110792.2(MECP2):​c.1198C>G​(p.Pro400Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000468 in 1,089,066 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 22 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P400L) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000055 ( 0 hom., 2 hem., cov: 20)
Exomes 𝑓: 0.000047 ( 0 hom. 22 hem. )
Failed GnomAD Quality Control

Consequence

MECP2
NM_001110792.2 missense

Scores

1
2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.964

Publications

6 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen, G2P
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 13 benign, 12 uncertain in NM_001110792.2
BP4
Computational evidence support a benign effect (MetaRNN=0.3394603).
BP6
Variant X-154030666-G-C is Benign according to our data. Variant chrX-154030666-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 156632.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAdExome4 at 51 XL,Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MECP2NM_001110792.2 linkc.1198C>G p.Pro400Ala missense_variant Exon 3 of 3 ENST00000453960.7 NP_001104262.1 P51608-2A0A140VKC4Q59FJ6
MECP2NM_004992.4 linkc.1162C>G p.Pro388Ala missense_variant Exon 4 of 4 ENST00000303391.11 NP_004983.1 P51608-1D3YJ43Q59FJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MECP2ENST00000453960.7 linkc.1198C>G p.Pro400Ala missense_variant Exon 3 of 3 1 NM_001110792.2 ENSP00000395535.2 P51608-2
MECP2ENST00000303391.11 linkc.1162C>G p.Pro388Ala missense_variant Exon 4 of 4 1 NM_004992.4 ENSP00000301948.6 P51608-1

Frequencies

GnomAD3 genomes
AF:
0.0000551
AC:
6
AN:
108899
Hom.:
0
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000115
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000346
AC:
6
AN:
173258
AF XY:
0.0000315
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000367
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000649
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000468
AC:
51
AN:
1089066
Hom.:
0
Cov.:
36
AF XY:
0.0000616
AC XY:
22
AN XY:
357116
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26264
American (AMR)
AF:
0.0000569
AC:
2
AN:
35145
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19324
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30153
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53959
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
36824
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3653
European-Non Finnish (NFE)
AF:
0.0000573
AC:
48
AN:
837906
Other (OTH)
AF:
0.0000218
AC:
1
AN:
45838
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.622
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000551
AC:
6
AN:
108899
Hom.:
0
Cov.:
20
AF XY:
0.0000641
AC XY:
2
AN XY:
31185
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29834
American (AMR)
AF:
0.00
AC:
0
AN:
10292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2608
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3454
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2469
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5816
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.000115
AC:
6
AN:
52049
Other (OTH)
AF:
0.00
AC:
0
AN:
1461
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000567
ExAC
AF:
0.00000827
AC:
1

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Severe neonatal-onset encephalopathy with microcephaly Benign:1
Aug 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Rett syndrome Benign:1
-
Molecular Genetics Laboratory, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 28, 2020
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Oct 28, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MECP2-related disorder Benign:1
Sep 16, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
16
DANN
Benign
0.39
DEOGEN2
Benign
0.25
T;.
FATHMM_MKL
Benign
0.72
D
LIST_S2
Uncertain
0.88
D;D
M_CAP
Pathogenic
0.55
D
MetaRNN
Benign
0.34
T;T
MetaSVM
Benign
-0.55
T
MutationAssessor
Benign
-0.20
N;.
PhyloP100
0.96
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.16
N;N
REVEL
Uncertain
0.39
Sift
Benign
0.65
T;T
Sift4G
Benign
0.064
T;T
Polyphen
0.0020
B;B
Vest4
0.34
MutPred
0.54
Loss of glycosylation at P388 (P = 0.0016);.;
MVP
0.82
ClinPred
0.019
T
GERP RS
4.7
Varity_R
0.082
gMVP
0.38
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61753000; hg19: chrX-153296117; API